尼弗林通过抑制树突细胞激活来减轻HDM诱导的过敏炎症
Qiao Wang1,2, Linlin Guo3,4, Ziling Zeng1,2
1Inflammation and Allergic Diseases Research Unit, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
Inflammation
|September 13, 2023
概括
尼弗林 (NEF) 通过抑制树突细胞中的NF-κB信号传递,保护免受室内灰尘 (HDM) 引起的过敏炎症. 这减少了炎症细胞和细胞因子,为过敏性疾病提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 室内灰尘 (HDM) 是一种常见的环境抗原,可引发慢性过敏疾病.
- 尼费林 (NEF) 以其抗炎性质而闻名.
- 了解NEF对HDM诱导过敏的保护机制至关重要.
研究的目的:
- 为了研究Neferine (NEF) 对室内灰尘 (HDM) 诱导的过敏炎症的保护作用.
- 阐明NEF治疗效果的潜在分子机制.
主要方法:
- 建立HDM诱导的过敏性喘小鼠模型.
- 组织学染色 (H&E,PAS) 用于肺组织分析.
- 流细胞测量用于免疫细胞分析.
- 用RT-PCR,ELISA和西布洛特进行细胞因子和信号通路分析.
- 在骨髓衍生的树突细胞 (BMDCs) 中进行研究.
主要成果:
- 在暴露于HDM的小鼠中,NEF显著降低了肺炎,杯状细胞增生和炎症指数.
- NEF抑制了Th2和Th17细胞群的增加及其相关的细胞因子 (IL-4,IL-13,IL-17).
- NEF 减少了 HDM 诱导的树突细胞 (DC),乙素,巨细胞和 ILC2 细胞的增加.
- 在肺组织和BMDC中,NEF减弱了NF-κB信号通路的激活.
- NEF 抑制了 HDM 激活的 DCs 促进 Th2 和 Th17 细胞分化.
结论:
- 尼费林 (NEF) 在小鼠模型中有效减轻HDM诱导的过敏炎症.
- NEF通过抑制树突细胞中的NF-κB信号通路来发挥其保护作用.
- NEF降低了关键的炎症媒介和参与过敏反应的免疫细胞群.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
Allergic Reactions
27.7K
Overview
27.7K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343
Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481


